Eli Lilly and Company (LLY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2003 | 12-2002 | 09-2002 | 06-2002 | 03-2002 | |
| Sales | 2,889,400 | 2,955,600 | 2,785,600 | 2,775,200 | 2,561,100 |
| Cost of Goods | 621,300 | 567,800 | 553,700 | 524,900 | 530,100 |
| Gross Profit | 2,268,100 | 2,387,800 | 2,231,900 | 2,250,300 | 2,031,000 |
| Operating Expenses | 1,444,400 | 1,495,900 | 1,422,100 | 1,461,600 | 1,280,200 |
| Operating Income | 824,000 | 892,700 | 810,500 | 789,600 | 750,900 |
| Interest Expense | 15,500 | 23,900 | 22,300 | 23,900 | 9,600 |
| Other Income | -314,600 | 75,200 | 74,600 | 78,500 | 65,400 |
| Pre-tax Income | 493,900 | 944,000 | 862,800 | 844,200 | 806,700 |
| Income Tax | 86,900 | 207,700 | 178,900 | 185,700 | 177,500 |
| Net Income Continuous | 407,000 | 736,300 | 683,900 | 658,500 | 629,200 |
| Net Income | $407,000 | $736,300 | $683,900 | $658,500 | $629,200 |
| EPS Basic Total Ops | 0.38 | 0.68 | 0.64 | 0.61 | 0.58 |
| EPS Basic Continuous Ops | 0.38 | 0.68 | 0.64 | 0.61 | 0.58 |
| EPS Diluted Total Ops | 0.38 | 0.68 | 0.63 | 0.61 | 0.58 |
| EPS Diluted Continuous Ops | 0.38 | 0.68 | 0.63 | 0.61 | 0.58 |
| EBITDA(a) | $968,600 | $992,401 | $941,100 | $920,900 | $882,300 |